MedPath

Preclinical and Clinical evaluation of ATHIMADHURA CHOORANAM (oral administration) in the management of JAUNDICE

Phase 2
Conditions
Health Condition 1: R17- Unspecified jaundice
Registration Number
CTRI/2022/10/046821
Lead Sponsor
Dr R S BRATHEESHA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Fever

2.Yellowish discoloration in sclera,skin and tongue

3.Dark yellow coloured urine

4.loss of appetite

5.Vomitting

6.Diarrhoea

7.Abdominal Pain

Exclusion Criteria

1.Children above 12 years

2.Children below 2 years

3.Jaundice due to Renal causes

4.Jaundice due to cardiac causes

5.Jaundice associated with cirrhosis of liver

6.Neonatal Jaundice

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study will help to understand the effects of ATHIMADHURA CHOORANAM in the management of MANJAL KAAMALAI in children and the specified symptoms of MANJAL KAAMALAI is expected to be curedTimepoint: 14 days
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath